哈罗制药

最新新闻

• 评级变动
  Analysts' Top NA Picks: Harrow Health (HROW), Scribe Therapeutics Inc. (SCTX)
  TipRanks · 2026/8/20
• 评级变动
  Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $91
  \u5e02\u573a\u8d44\u8baf · 2026/3/18
• 评级变动
  H.C. Wainwright Remains a Buy on Harrow Health (HROW)
  TipRanks · 2026/5/14
• 评级变动
  B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $60
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)
  TipRanks · 2026/8/20
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Hims & Hers Health (HIMS) and ArriVent BioPharma, Inc. (AVBP)
  TipRanks · 2026/5/12
• Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $60
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Caris Life Sciences, Inc. (CAI)
  TipRanks · 2026/8/7
• 评级变动
  Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $88
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $60
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• 评级变动
  Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Amentum Holdings, Inc. (AMTM)
  TipRanks · 2026/8/11
• 评级变动
  B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $65
  \u5e02\u573a\u8d44\u8baf · 2026/4/7
• 评级变动
  A Quick Look at Today's Ratings for Harrow(HROW.US), With a Forecast Between $60 to $91
  \u5e02\u573a\u8d44\u8baf · 2026/3/5
• 评级变动
  Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating, Announces Target Price $59
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• Leerink Partners Initiates Harrow(HROW.US) With Buy Rating, Announces Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• BTIG Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $63
  \u5e02\u573a\u8d44\u8baf · 2026/8/26
• Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  H.C. Wainwright Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $70
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• William Blair Maintains Harrow(HROW.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $88
  \u5e02\u573a\u8d44\u8baf · 2026/5/13

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。